Navigation Links
Polypill for Heart Ailments Being Tested in India

The Dr Reddy's Laboratories (DRL), a leading Indian pharmaceutical firm, says it is conducting the first-ever clinical trials for an all-in-one polypill// for heart problems on 250 patients in the country. According to Raghu Cidambi of DRL, "We hope to put it in the market by the end of this year."

The proposed polypill will contain drugs for dilating arteries, relaxing heart muscles, removing excess water and salts, preventing clot formation, and reducing "bad" cholesterol.

The subjects of the trial have all already suffered a cardiac event. The trial is for establishing whether the polypill can prevent recurrence of cardiac problems.

Though a polypill was first suggested by two British scientists in 2003, this is the first time such a drug is being tested anywhere in the world on human subjects.

If the trials succeed, the polypill may have a worldwide market. Every year, over 17.5 million persons die due to heart diseases all over the world. India has the dubious distinction of having the largest share - over 1.5 million.

By 2010, India is projected to have 60% of the world's heart patients fuelled by risky lifestyles — which include junk food, lack of exercise and smoking — and the increasing number of elderly people.

The DRL is hoping to open up yet another vista. Even those who have not suffered an attack or a stroke could take the polypill if they think that they are liable to fall victim to cardio-vascular diseases.

Clinical trials to establish that aspect of the drug would start after necessary permission is granted by the Drug Controller of India.

However experts say such one-size-fits-all approach may not work. They note that dosage may vary from person to person.

Besides it could make people complacent about risk factors like smoking, diet, stress and exercise, they caution.
SR
'"/>




Page: 1

Related medicine news :

1. “Polypill”- to prevent recurrent heart diseass
2. Dr. Reddys To Launch Polypill For Treating Heart Disease
3. One in Three Heart Attack Patients Have No Chest Pains
4. Epileptic Seizures Can Be Due to Heart Problem
5. Bypass Heart Surgery Performed Without General Anesthesia
6. New CPR Guidelines issued by Heart Association
7. White Cells Count Can Predict Heart Attack Death Risk
8. Vitamins-The answer to Heart Disease?
9. Fight Heart disease and Pain with Meditation
10. Heart disease in the newborn is related to maternal malnutrition
11. New drug to treat Heart Attack and damaged tissue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: